Results 231 to 240 of about 382,920 (355)

The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma

Haematologica, 2017
Sharmilan Thanendrarajan, Erming Tian, Pingping Qu, Pankaj Mathur, Carolina Schinke, Frits van Rhee, Maurizio Zangari, Leo Rasche, Niels Weinhold, Daisy Alapat, William Bellamy, Cody Ashby, Sandra Mattox, Joshua Epstein, Shmuel Yaccoby, Bart Barlogie, Antje Hoering, Michael Bauer, Brian A. Walker, Faith E. Davies, Gareth J. Morgan   +20 more
doaj   +1 more source

The miR4261/PAMM axis in multiple myeloma promotes bone resorption. [PDF]

Sci Rep
Cui J, Bian S, Hao Z, Zhang X, Zhang C, Zhao Y, Zhang X, Wang H.   +7 more
europepmc   +1 more source

Lactate Dehydrogenase A and a Novel Four‐Gene Signature as Dual Diagnostic Markers for Lung Adenocarcinoma and Ischemic Stroke

Medicine Advances, EarlyView.
This study identified shared molecular alterations between lung adenocarcinoma (LUAD) and ischemic stroke (IS) through integrative transcriptomic analysis of TCGA‐LUAD and GSE146882 datasets, revealing a four‐gene diagnostic signature (LDHA, NME4, SLC25A39, and SLC7A5) with high accuracy across both diseases. Among these, LDHA was further identified as
Jin Xie, Gao‐Chun Xiao, Xin‐Yang Qu, Rui‐Min Wu, Yu‐Long Zou, Xue Hu, Xu‐Sheng Liu   +6 more
wiley   +1 more source

Multiplexed Imaging Reveals Immune-Metabolic Niches in Multiple Myeloma Linked to Progression and Bone Disease. [PDF]

Blood Cancer Discov
Roseth IA, Hatscher L, Schiller C, Johnstuen HSS, Slørdahl TS, Hov H, Schapiro D, Standal T.   +7 more
europepmc   +1 more source

Prime editing in neuropsychiatric disorders: From mutation‐specific target selection to clinical translation

Neuroprotection, EarlyView.
Abstract Prime editing, a novel clustered regularly interspaced short palindromic repeats (CRISPR)‐based technology, fuses a reverse transcriptase (RT) to an engineered CRISPR‐associated protein 9 (Cas9) and uses a prime editing guide RNA (pegRNA)‐encoded template.
Tianshan Ji, Yuan Zhang, Jinyi Zhao, Yiping Lu, Chengkun Wang   +4 more
wiley   +1 more source

Forimtamig: a potent GPRC5D-targeted bispecific antibody in multiple myeloma. [PDF]

Ann Med Surg (Lond)
Ali H, Hilal H, Gul M, Asad M, Jaber Amin MH.   +4 more
europepmc   +1 more source

Targeting fibrosis in the treatment of lower urinary tract dysfunction

The Journal of Pathology, EarlyView.
Abstract Benign prostatic hyperplasia (BPH) is a widely prevalent age‐associated disease that is the main contributor to lower urinary tract dysfunction (LUTD) in aging men. Although prostate fibrosis has been recognized as a contributor to BPH pathophysiology, there are not any clinically available therapeutics that target this aspect of disease ...
Ajinkya R Limkar, Sophia M Vrba, Emily A Ricke, Zsuzsanna Fabry, Matthew S Lee, Kevin T McVary, William A Ricke   +6 more
wiley   +1 more source

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

British Journal of Haematology, 2003
R. Kyle, J. Child, K. Anderson, B. Barlogie, R. Bataille, W. Bensinger, J. Bladé, M. Boccadoro, W. Dalton, M. Dimopoulos, B. Djulbegovic, M. Drayson, B. Durie, T. Facon, R. Fonseca, G. Gahrton, P. Greipp, J. Harousseau, D. Harrington, M. Hussein, D. Joshua, H. Ludwig, G. Morgan, M. Oken, R. Powles, P. Richardson, D. Roodman, J. Miguel, K. Shimizu, C. Shustik, B. Sirohi, P. Sonneveld, G. Tricot, I. Turesson, B. Ness, D. Vesole, D. Weber, J. Westin, K. Wheatley   +38 more
semanticscholar   +1 more source

Tracheal Extramedullary Plasmacytoma Causing Near-Complete Airway Obstruction in an HIV-Positive Man: A Case Report and Brief Literature Review. [PDF]

Clin Case Rep
Tsegay F, Dawud EM, Bekele A, Bitew A, Yusuf H, Shukri MK, Yonis AY, Bejiga YD, Birara ED, Anberber HM, Woyimo TG.   +10 more
europepmc   +1 more source

Multiple myeloma

HemaSphere, 2019
openaire   +4 more sources